Home | Coriolis Pharma

Upcoming Webinar: Polysorbate - an excellent stabilizer with a dark side

Register now to join the talk by our CSO Dr. Andrea Hawe

Read More

About us

Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines.

As a privately-held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients.

Formulation Development

Formulation Development

“It is a medicine, not a molecule, that we are giving to the patient” Marc B. Brown, 2005.

Coriolis is the expert in developing liquid and lyophilized formulations for a large variety of different (bio)pharmaceutical molecules, including proteins, peptides, nucleic acids, ATMPs, GMOs, vaccines and virus(-like) particles.

Find out how we can support your drug development...

Read more

Analytical Services

Analytical Services

A highly diverse analytical portfolio entirely performed in-house: This is Coriolis.

With the latest in technology and highly experienced scientists, we are a trendsetter in the field. We provide our analytical services for samples up to biosafety level S2 under R&D and cGMP conditions, including method development, qualification and validation.

Get to know our services...

Read more

About us

About us

Independent, reliable and always on the cutting edge of science. Coriolis is a leading service provider for formulation research and development of (bio)pharmaceutical drugs and vaccines.

Get to know us...

Read more

Latest news

Coriolis supports BioM Science & Health Forum

Coriolis supports live discussion forum BioM Science & Health

The BioM Forum is an interdisciplinary discussion platform making scientific viewpoints available to the public. Coriolis is gold sponsors of the next session about mRNA and gene therapy.

Prof. Dr. Susumu Uchiyama joins Scientific Advisory Board of Coriolis

Prof. Dr. Susumu Uchiyama joins Scientific Advisory Board of Coriolis

We welcome Prof. Dr. Susumu Uchiyama as a new Scientific Advisory Board Member and expert for viral vectors for gene therapy.

Coriolis-sponsored sailing team happy with 2021 world cup race

Coriolis-sponsored sailing team happy with 2021 world cup race

The GFK racing team achieved a fantastic 10th place at the H-boat world cup race in Denmark.

We mourn Prof. Dr. Wim Jiskoot (1961 – 2021), Scientific Advisor of Coriolis

In Memoriam Prof. Dr. Wim Jiskoot (1961 – 2021), Scientific Advisor of Coriolis

We will remember Wim as the openminded, brilliant, and honest person, who stayed positive even after a devastating diagnosis. Our thoughts are with his loved ones, in particular Karin, Julia and Carles.

Coriolis Scientist contributes to "Bioanalytik" by Lottspeich

Coriolis Scientist contributes to "Bioanalytik" by Lottspeich

Our AUC expert Dr. Klaus Richter co-authors chapter about protein interactions in Lottspeich's standard reference book "Bioanalytik"

Coriolis helps victims of flood catastrophe

Coriolis helps victims of flood catastrophe

Coriolis supports the emergency aid by Germany's Relief Coalition with donation. Our thoughts are with those who lost relatives and friends.

Prof. Dr. Olivia Merkel joins Scientific Advisory Board of Coriolis Pharma

Prof. Dr. Olivia Merkel joins our Scientific Advisory Board

We welcome Prof. Dr. Olivia Merkel as a new Scientific Advisory Board Member and expert for targeted mRNA delivery

GFK Sailing Team

Coriolis Supports Local Sailing Team on „Road to Sweden 2023” Project

The ambitious goal of the GFK sailing team is a top ten rank in the world championship in 2023.

Coriolis Pharma expands its ATMP development facilities

Coriolis Pharma expands its ATMP development facilities

Constructions of new facilities for ATMP formulation development up to biosafety level S2 are in progress and operations are expected to start by Q4 2021

Prof. Ernst Wagner joins Coriolis Pharma’s Scientific Advisory Board

Prof. Ernst Wagner joins Coriolis Pharma’s Scientific Advisory Board as expert for nucleic acid therapeutics

We welcome Prof. Dr. Ernst Wagner as new Scientific Advisory Board Member and expert for nucleic acid therapeutics

Latest publications

Forced degradation of cell-based medicinal products guided by flow imaging microscopy: explorative studies with Jurkat cells

A D Grabarek, W Jiskoot, A Hawe, K Pike-Overzet, T Menzen

Protein-Protein Interaction

Peter Uetz, Eva-Kathrin Ehmoser, Dagmar Klostermeier, Klaus Richter & Ute Curth.
Editors: Jens Kurreck, Joachim Engels & Friedrich Lottspeich.

Comparison of Different Liquid Chromatography-Based Purification Strategies for Adeno-Associated Virus Vectors

Ruth Rieser, Johanna Koch, Greta Faccioli, Klaus Richter, Tim Menzen, Martin Biel, Gerhard Winter, Stylianos Michalakis

Combining Unfolding Reversibility Studies and Molecular Dynamics Simulations to Select Aggregation-Resistant Antibodies

Berner C, Menzen T, Winter G, Svilenov HL.

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, Crommelin DJA

Formulation of Cell-Based Medicinal Products: A Question of Life or Death?

Karin H Hoogendoorn, Daan J A Crommelin, Wim Jiskoot

Addressing the Cold Reality of mRNA Vaccine Stability.

Daan J A Crommelin, Thomas J Anchordoquy, David B Volkin, Wim Jiskoot, Enrico Mastrobattista

The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines

Daan J A Crommelin, David B Volkin, Karin H Hoogendoorn, Anthony S Lubiniecki, Wim Jiskoot

Oil-Immersion Flow Imaging Microscopy for Quantification and Morphological Characterization of Submicron Particles in Biopharmaceuticals

Krause N, Kuhn S, Frotscher E, Nikels F, Hawe A, Garidel P, Menzen T.

Immunological Evaluation In Vitro of Nanoparticulate Impurities Isolated From Pharmaceutical-Grade Sucrose

Grabarek A, Nabhan M, Turbica I, Hawe A, Pallardy M, Jiskoot W.